Clinical Effectiveness and Cost-Effectiveness of Use of Therapeutic Monitoring of Tumour Necrosis Factor Alpha (TNF-α) Inhibitors [LISA-TRACKER® Enzyme-Linked Immunosorbent Assay (ELISA) Kits, TNF-α-Blocker ELISA Kits and Promonitor® ELISA Kits] Versus Standard Care in Patients With Crohn’s Disease: Systematic Reviews and Economic Modelling

Health Technology Assessment - United Kingdom
doi 10.3310/hta20830

Related search